May 21, 2025 — Corify Care recently announced it has entered into a know-how agreement with Mayo Clinic. Corify Care is an AI-driven medical technology company specializing in global cardiac mapping and real-time precision guidance for the treatment of cardiac arrhythmias.
Nearly 60 million people worldwide are affected by atrial fibrillation, yet treatment outcomes for complex cases remain ineffective. More than 50 percent of ablation procedures for complex arrhythmia fail, in many cases because clinicians are unable to target the necessary region of the heart. Corify’s global mapping technology now allows clinicians to pinpoint the source of an atrial fibrillation case, creating an accurate roadmap for completing a targeted ablation.
As part of the collaboration, select Mayo Clinic physicians will help Corify refine its current model and make recommendations on improvements relating to useability and clinical flow.
“This collaboration focuses on advancing AI-powered technology for real-time cardiac mapping and enhanced procedural guidance in arrhythmia treatment,’’ said Andreu Climent, CEO of Corify Care.
Corify Care’s proprietary technology offers a global and efficient solution to detect, map, and manage complex cardiac arrhythmias with unprecedented speed and accuracy. Unlike traditional invasive diagnostic methods, Corify Care’s system creates detailed three-dimensional maps of the heart’s electrical activity — offering a faster approach to arrhythmia diagnosis and management. Ultimately this technology aims to provide more effective treatment and a reduced risk of recurrence, saving and improving more patients’ lives.
Recent clinical research confirmed that Corify’s imageless ECGI system enables noninvasive, real-time cardiac mapping without the need for CT or MRI and can be applied across a wide range of procedures including atrial fibrillation, ventricular tachycardia, and cardiac resynchronization therapy.
For more information about Corify Care, please visit https://corify.es/.
November 14, 2025 
